Associations of genetic markers of diabetes mellitus with carotid atherosclerosis: a community-based case–control study

[1] Björkegren JLM(2022)Atherosclerosis: recent developments Cell 185 1630-1645

[2] Lusis AJ(2007)Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications Cell Biochem Biophys 49 48-63

[3] Vasdev S(2019)The atherogenic role of circulating modified lipids in atherosclerosis Int J Mol Sci 20 3561-2503

[4] Gill V(2013)Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis PLoS ONE 8 2493-3021

[5] Singal P(1994)Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 46-248

[6] Summerhill VI(2009)Atherosclerosis profile and incidence of cardiovascular events: a population- based survey BMC Cardiovasc Disord 9 2982-867

[7] Grechko AV(2020)Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study J Am Coll Cardiol 76 217-1221

[8] Yet SF(2017)2017 Taiwan lipid guidelines for high risk patients J Formos Med Assoc 116 850-323

[9] Sobenin IA(2015)Diabetes mellitus: the epidemic of the century World J Diabetes 6 1212-1467

[10] Orekhov AN(2009)Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men Diabetes 58 255-1140

[1] Björkegren JLM(2022)Atherosclerosis: recent developments Cell 185 1630-1645

[2] Lusis AJ(2007)Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications Cell Biochem Biophys 49 48-63

[3] Vasdev S(2019)The atherogenic role of circulating modified lipids in atherosclerosis Int J Mol Sci 20 3561-2503

[4] Gill V(2013)Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis PLoS ONE 8 2493-3021

[5] Singal P(1994)Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 46-248

[6] Summerhill VI(2009)Atherosclerosis profile and incidence of cardiovascular events: a population- based survey BMC Cardiovasc Disord 9 2982-867

[7] Grechko AV(2020)Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study J Am Coll Cardiol 76 217-1221

[8] Yet SF(2017)2017 Taiwan lipid guidelines for high risk patients J Formos Med Assoc 116 850-323

[9] Sobenin IA(2015)Diabetes mellitus: the epidemic of the century World J Diabetes 6 1212-1467

[10] Orekhov AN(2009)Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men Diabetes 58 255-1140